Nth Analytics

Executive Summary

Nth Analytics is a Boston-based specialized clinical research organization (CRO) focused on biostatistics and SAS programming for pharmaceutical and biotech companies. Founded in 2019, the company leverages a lean team of expert statisticians and programmers to manage mission-critical data analysis and regulatory submissions. By emphasizing CDISC standards and integrating AI/ML capabilities into clinical trial data workflows, Nth Analytics positions itself at the forefront of technological innovation in the CRO space. Its niche expertise and small-team agility allow it to serve as a reliable partner for biopharma clients seeking efficient, high-quality biostatistical support. As the demand for data-driven clinical development grows, particularly with the rise of complex trial designs and regulatory requirements, Nth Analytics is well-positioned to capture a larger share of the outsourced biostatistics market. The company's focus on advanced analytics and regulatory compliance provides a competitive edge, though its small scale may limit capacity for large-scale contracts.

Upcoming Catalysts (preview)

• Q3 2026Expansion of AI/ML Service Offerings60% success
• Q3 2026Key Partnership with Mid-Size Pharma Company50% success
• TBDSuccessful Completion of Regulatory Submission for a Major Client75% success